[ab5bfb]: / data / text / Van_MacGyver_ce9f4463-d048-cc81-411a-58ae17855d1a.txt

Download this file

187 lines (186 with data), 14.9 kB

  1
  2
  3
  4
  5
  6
  7
  8
  9
 10
 11
 12
 13
 14
 15
 16
 17
 18
 19
 20
 21
 22
 23
 24
 25
 26
 27
 28
 29
 30
 31
 32
 33
 34
 35
 36
 37
 38
 39
 40
 41
 42
 43
 44
 45
 46
 47
 48
 49
 50
 51
 52
 53
 54
 55
 56
 57
 58
 59
 60
 61
 62
 63
 64
 65
 66
 67
 68
 69
 70
 71
 72
 73
 74
 75
 76
 77
 78
 79
 80
 81
 82
 83
 84
 85
 86
 87
 88
 89
 90
 91
 92
 93
 94
 95
 96
 97
 98
 99
100
101
102
103
104
105
106
107
108
109
110
111
112
113
114
115
116
117
118
119
120
121
122
123
124
125
126
127
128
129
130
131
132
133
134
135
136
137
138
139
140
141
142
143
144
145
146
147
148
149
150
151
152
153
154
155
156
157
158
159
160
161
162
163
164
165
166
167
168
169
170
171
172
173
174
175
176
177
178
179
180
181
182
183
184
185
186
Van MacGyver
============
Race: Asian
Ethnicity: Non-Hispanic
Gender: F
Age: 10
Birth Date: 2012-03-11
Marital Status: S
--------------------------------------------------------------------------------
ALLERGIES:
2013-01-16 - : Cow's milk (substance)
2013-01-16 - : Lisinopril
2013-01-16 - : Tree pollen (substance)
2013-01-16 - : Grass pollen (substance)
2013-01-16 - : Animal dander (substance)
2013-01-16 - : House dust mite (organism)
2013-01-16 - : Mold (organism)
2013-01-16 - : Latex (substance)
--------------------------------------------------------------------------------
MEDICATIONS:
2022-03-20[CURRENT] : NDA021457 200 ACTUAT albuterol 0.09 MG/ACTUAT Metered Dose Inhaler [ProAir] for Childhood asthma
2022-03-20[CURRENT] : 120 ACTUAT fluticasone propionate 0.044 MG/ACTUAT Metered Dose Inhaler [Flovent] for Childhood asthma
2022-01-23[STOPPED] : Acetaminophen 160 MG Chewable Tablet
2021-03-14[STOPPED] : NDA021457 200 ACTUAT albuterol 0.09 MG/ACTUAT Metered Dose Inhaler [ProAir] for Childhood asthma
2021-03-14[STOPPED] : 120 ACTUAT fluticasone propionate 0.044 MG/ACTUAT Metered Dose Inhaler [Flovent] for Childhood asthma
2020-03-08[STOPPED] : NDA021457 200 ACTUAT albuterol 0.09 MG/ACTUAT Metered Dose Inhaler [ProAir] for Childhood asthma
2020-03-08[STOPPED] : 120 ACTUAT fluticasone propionate 0.044 MG/ACTUAT Metered Dose Inhaler [Flovent] for Childhood asthma
2019-03-03[STOPPED] : NDA021457 200 ACTUAT albuterol 0.09 MG/ACTUAT Metered Dose Inhaler [ProAir] for Childhood asthma
2019-03-03[STOPPED] : 120 ACTUAT fluticasone propionate 0.044 MG/ACTUAT Metered Dose Inhaler [Flovent] for Childhood asthma
2018-02-25[STOPPED] : NDA021457 200 ACTUAT albuterol 0.09 MG/ACTUAT Metered Dose Inhaler [ProAir] for Childhood asthma
2018-02-25[STOPPED] : 120 ACTUAT fluticasone propionate 0.044 MG/ACTUAT Metered Dose Inhaler [Flovent] for Childhood asthma
2017-06-11[STOPPED] : NDA021457 200 ACTUAT albuterol 0.09 MG/ACTUAT Metered Dose Inhaler [ProAir] for Childhood asthma
2017-06-11[STOPPED] : 120 ACTUAT fluticasone propionate 0.044 MG/ACTUAT Metered Dose Inhaler [Flovent] for Childhood asthma
2017-02-19[STOPPED] : NDA021457 200 ACTUAT albuterol 0.09 MG/ACTUAT Metered Dose Inhaler [ProAir] for Childhood asthma
2017-02-19[STOPPED] : 120 ACTUAT fluticasone propionate 0.044 MG/ACTUAT Metered Dose Inhaler [Flovent] for Childhood asthma
2016-02-14[STOPPED] : NDA021457 200 ACTUAT albuterol 0.09 MG/ACTUAT Metered Dose Inhaler [ProAir] for Childhood asthma
2016-02-14[STOPPED] : 120 ACTUAT fluticasone propionate 0.044 MG/ACTUAT Metered Dose Inhaler [Flovent] for Childhood asthma
2015-08-16[STOPPED] : NDA021457 200 ACTUAT albuterol 0.09 MG/ACTUAT Metered Dose Inhaler [ProAir] for Childhood asthma
2015-08-16[STOPPED] : 120 ACTUAT fluticasone propionate 0.044 MG/ACTUAT Metered Dose Inhaler [Flovent] for Childhood asthma
2015-02-15[STOPPED] : NDA021457 200 ACTUAT albuterol 0.09 MG/ACTUAT Metered Dose Inhaler [ProAir] for Childhood asthma
2015-02-15[STOPPED] : 120 ACTUAT fluticasone propionate 0.044 MG/ACTUAT Metered Dose Inhaler [Flovent] for Childhood asthma
2014-11-09[STOPPED] : NDA021457 200 ACTUAT albuterol 0.09 MG/ACTUAT Metered Dose Inhaler [ProAir] for Childhood asthma
2014-11-09[STOPPED] : 120 ACTUAT fluticasone propionate 0.044 MG/ACTUAT Metered Dose Inhaler [Flovent] for Childhood asthma
2014-08-17[STOPPED] : NDA021457 200 ACTUAT albuterol 0.09 MG/ACTUAT Metered Dose Inhaler [ProAir] for Childhood asthma
2014-08-17[STOPPED] : 120 ACTUAT fluticasone propionate 0.044 MG/ACTUAT Metered Dose Inhaler [Flovent] for Childhood asthma
2014-06-13[STOPPED] : NDA021457 200 ACTUAT albuterol 0.09 MG/ACTUAT Metered Dose Inhaler [ProAir] for Childhood asthma
2014-06-13[STOPPED] : 120 ACTUAT fluticasone propionate 0.044 MG/ACTUAT Metered Dose Inhaler [Flovent] for Childhood asthma
2013-01-16[CURRENT] : NDA020800 0.3 ML Epinephrine 1 MG/ML Auto-Injector
2013-01-16[CURRENT] : cetirizine hydrochloride 5 MG Oral Tablet
--------------------------------------------------------------------------------
CONDITIONS:
2022-01-23 - 2022-02-12 : Facial laceration
2021-01-18 - 2021-09-17 : Child attention deficit disorder
2021-01-11 - 2021-02-17 : COVID-19
2021-01-11 - 2021-01-11 : Suspected COVID-19
2021-01-11 - 2021-02-17 : Joint pain (finding)
2021-01-11 - 2021-02-17 : Muscle pain (finding)
2021-01-11 - 2021-02-17 : Sore throat symptom (finding)
2021-01-11 - 2021-02-17 : Cough (finding)
2014-06-13 - : Childhood asthma
--------------------------------------------------------------------------------
CARE PLANS:
2022-01-23[STOPPED] : Wound care
Reason: Facial laceration
Activity: Dressing change management
Activity: Behavior to prevent infection
2021-01-18[STOPPED] : Overactivity/inattention behavior management
Activity: Counseling
Activity: Psychological assessment
2021-01-11[STOPPED] : Infectious disease care plan (record artifact)
Activity: Airborne precautions (procedure)
Activity: Isolation of infected patient (procedure)
2021-01-11[STOPPED] : Infectious disease care plan (record artifact)
Activity: Airborne precautions (procedure)
Activity: Personal protective equipment (physical object)
2014-06-13[CURRENT] : Asthma self management
Reason: Childhood asthma
Activity: Inhaled steroid therapy
Activity: Home nebulizer therapy
Activity: Breathing control
2013-01-03[CURRENT] : Self-care interventions (procedure)
Activity: Food allergy diet
Activity: Allergy education
Activity: Allergy education
--------------------------------------------------------------------------------
REPORTS:
2021-01-11 : SARS-CoV-2 RNA Pnl Resp NAA+probe
- SARS-CoV-2 RNA Pnl Resp NAA+probe Detected (qualifier value)
2021-01-11 : Respiratory pathogens DNA and RNA panel - Respiratory specimen by NAA with probe detection
- Influenza virus A RNA [Presence] in Respiratory specimen by NAA with probe detection Negative (qualifier value)
- Influenza virus B RNA [Presence] in Respiratory specimen by NAA with probe detection Negative (qualifier value)
- Respiratory syncytial virus RNA [Presence] in Respiratory specimen by NAA with probe detection Negative (qualifier value)
- Parainfluenza virus 1 RNA [Presence] in Respiratory specimen by NAA with probe detection Negative (qualifier value)
- Parainfluenza virus 2 RNA [Presence] in Respiratory specimen by NAA with probe detection Negative (qualifier value)
- Parainfluenza virus 3 RNA [Presence] in Respiratory specimen by NAA with probe detection Negative (qualifier value)
- Rhinovirus RNA [Presence] in Respiratory specimen by NAA with probe detection Negative (qualifier value)
- Human metapneumovirus RNA [Presence] in Respiratory specimen by NAA with probe detection Negative (qualifier value)
- Adenovirus A+B+C+D+E DNA [Presence] in Respiratory specimen by NAA with probe detection Negative (qualifier value)
--------------------------------------------------------------------------------
OBSERVATIONS:
2022-03-20 : Tobacco smoking status Never smoked tobacco (finding)
2022-03-20 : Respiratory rate 15.0 /min
2022-03-20 : Heart rate 85.0 /min
2022-03-20 : Blood Pressure
- Diastolic Blood Pressure 72.0 mm[Hg]
- Systolic Blood Pressure 130.0 mm[Hg]
2022-03-20 : Body mass index (BMI) [Percentile] Per age and gender 66.4 %
2022-03-20 : Body Mass Index 17.9 kg/m2
2022-03-20 : Body Weight 30.5 kg
2022-03-20 : Pain severity - 0-10 verbal numeric rating [Score] - Reported 1.0 {score}
2022-03-20 : Body Height 130.5 cm
2021-03-14 : Tobacco smoking status Never smoked tobacco (finding)
2021-03-14 : Respiratory rate 14.0 /min
2021-03-14 : Heart rate 69.0 /min
2021-03-14 : Blood Pressure
- Diastolic Blood Pressure 77.0 mm[Hg]
- Systolic Blood Pressure 114.0 mm[Hg]
2021-03-14 : Body mass index (BMI) [Percentile] Per age and gender 71.0 %
2021-03-14 : Body Mass Index 17.6 kg/m2
2021-03-14 : Body Weight 28.0 kg
2021-03-14 : Pain severity - 0-10 verbal numeric rating [Score] - Reported 2.0 {score}
2021-03-14 : Body Height 126.0 cm
2021-01-11 : SARS-CoV-2 RNA Pnl Resp NAA+probe Detected (qualifier value)
2021-01-11 : Adenovirus A+B+C+D+E DNA [Presence] in Respiratory specimen by NAA with probe detection Negative (qualifier value)
2021-01-11 : Human metapneumovirus RNA [Presence] in Respiratory specimen by NAA with probe detection Negative (qualifier value)
2021-01-11 : Rhinovirus RNA [Presence] in Respiratory specimen by NAA with probe detection Negative (qualifier value)
2021-01-11 : Parainfluenza virus 3 RNA [Presence] in Respiratory specimen by NAA with probe detection Negative (qualifier value)
2021-01-11 : Parainfluenza virus 2 RNA [Presence] in Respiratory specimen by NAA with probe detection Negative (qualifier value)
2021-01-11 : Parainfluenza virus 1 RNA [Presence] in Respiratory specimen by NAA with probe detection Negative (qualifier value)
2021-01-11 : Respiratory syncytial virus RNA [Presence] in Respiratory specimen by NAA with probe detection Negative (qualifier value)
2021-01-11 : Influenza virus B RNA [Presence] in Respiratory specimen by NAA with probe detection Negative (qualifier value)
2021-01-11 : Influenza virus A RNA [Presence] in Respiratory specimen by NAA with probe detection Negative (qualifier value)
2021-01-11 : Body Weight 27.3 kg
2021-01-11 : Blood Pressure
- Diastolic Blood Pressure 73.0 mm[Hg]
- Systolic Blood Pressure 123.0 mm[Hg]
2021-01-11 : Oxygen saturation in Arterial blood 75.5 %
2021-01-11 : Heart rate 69.5 /min
2021-01-11 : Respiratory rate 26.5 /min
2021-01-11 : Body temperature 41.0 Cel
--------------------------------------------------------------------------------
PROCEDURES:
2022-01-23 : Suture open wound for Facial laceration
2021-09-17 : Cognitive and behavioral therapy for Child attention deficit disorder
2021-08-09 : Cognitive and behavioral therapy for Child attention deficit disorder
2021-06-29 : Cognitive and behavioral therapy for Child attention deficit disorder
2021-05-29 : Cognitive and behavioral therapy for Child attention deficit disorder
2021-04-19 : Cognitive and behavioral therapy for Child attention deficit disorder
2021-03-20 : Cognitive and behavioral therapy for Child attention deficit disorder
2021-03-14 : Medication Reconciliation (procedure)
2021-02-20 : Cognitive and behavioral therapy for Child attention deficit disorder
2021-01-11 : Face mask (physical object) for Suspected COVID-19
--------------------------------------------------------------------------------
IMMUNIZATIONS:
2022-03-20 : Influenza, seasonal, injectable, preservative free
2021-03-14 : Influenza, seasonal, injectable, preservative free
--------------------------------------------------------------------------------
ENCOUNTERS:
2022-03-20 (Dr. Quentin Fritsch) : Encounter at RIVER'S EDGE PRIMARY CARE LLC
2022-01-23 (Dr. Burton Schoen) : Encounter at EXCEL HOME CARE SERVICES INC
2021-09-17 (Dr. Cletus Paucek) : Encounter at ENCOMPASS HEALTH REHAB HOSPITAL OF WESTERN MASS : Encounter for Child attention deficit disorder
2021-08-09 (Dr. Cletus Paucek) : Encounter at ENCOMPASS HEALTH REHAB HOSPITAL OF WESTERN MASS : Encounter for Child attention deficit disorder
2021-06-29 (Dr. Cletus Paucek) : Encounter at ENCOMPASS HEALTH REHAB HOSPITAL OF WESTERN MASS : Encounter for Child attention deficit disorder
2021-05-29 (Dr. Cletus Paucek) : Encounter at ENCOMPASS HEALTH REHAB HOSPITAL OF WESTERN MASS : Encounter for Child attention deficit disorder
2021-04-19 (Dr. Cletus Paucek) : Encounter at ENCOMPASS HEALTH REHAB HOSPITAL OF WESTERN MASS : Encounter for Child attention deficit disorder
2021-03-20 (Dr. Cletus Paucek) : Encounter at ENCOMPASS HEALTH REHAB HOSPITAL OF WESTERN MASS : Encounter for Child attention deficit disorder
2021-03-14 (Dr. Quentin Fritsch) : Encounter at RIVER'S EDGE PRIMARY CARE LLC
2021-02-20 (Dr. Cletus Paucek) : Encounter at ENCOMPASS HEALTH REHAB HOSPITAL OF WESTERN MASS : Encounter for Child attention deficit disorder
2021-01-18 (Dr. Cletus Paucek) : Encounter at ENCOMPASS HEALTH REHAB HOSPITAL OF WESTERN MASS : Encounter for Child attention deficit disorder
2021-01-11 (Dr. Cletus Paucek) : Encounter at ENCOMPASS HEALTH REHAB HOSPITAL OF WESTERN MASS
2020-03-08 (Dr. Quentin Fritsch) : Encounter at RIVER'S EDGE PRIMARY CARE LLC
2019-03-03 (Dr. Quentin Fritsch) : Encounter at RIVER'S EDGE PRIMARY CARE LLC
2018-02-25 (Dr. Quentin Fritsch) : Encounter at RIVER'S EDGE PRIMARY CARE LLC
2017-06-10 (Dr. Cletus Paucek) : Encounter at ENCOMPASS HEALTH REHAB HOSPITAL OF WESTERN MASS : Encounter for Viral sinusitis (disorder)
2017-02-19 (Dr. Quentin Fritsch) : Encounter at RIVER'S EDGE PRIMARY CARE LLC
2016-02-14 (Dr. Quentin Fritsch) : Encounter at RIVER'S EDGE PRIMARY CARE LLC
2015-08-16 (Dr. Quentin Fritsch) : Encounter at RIVER'S EDGE PRIMARY CARE LLC
2015-02-15 (Dr. Quentin Fritsch) : Encounter at RIVER'S EDGE PRIMARY CARE LLC
2014-11-09 (Dr. Cletus Paucek) : Encounter at ENCOMPASS HEALTH REHAB HOSPITAL OF WESTERN MASS
2014-08-17 (Dr. Quentin Fritsch) : Encounter at RIVER'S EDGE PRIMARY CARE LLC
2014-06-13 (Dr. Cletus Paucek) : Encounter at ENCOMPASS HEALTH REHAB HOSPITAL OF WESTERN MASS : Encounter for Childhood asthma
2013-01-16 (Dr. Cletus Paucek) : Encounter at ENCOMPASS HEALTH REHAB HOSPITAL OF WESTERN MASS
2013-01-03 (Dr. Cletus Paucek) : Encounter at ENCOMPASS HEALTH REHAB HOSPITAL OF WESTERN MASS
--------------------------------------------------------------------------------
IMAGING STUDIES:
--------------------------------------------------------------------------------